This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Munn, D. H. Articles by Armstrong, E. Search for Related Content PubMed PubMed Citation Articles by Munn, D. H. Articles by Armstrong, E.

Cytokine Regulation of Human Monocyte Differentiation in Vitro: The Tumor-Cytotoxic Phenotype Induced by Macrophage Colony-stimulating Factor Is Developmentally Regulated by -Interferon¹

Division of Pediatric Hematology-Oncology, Medical College of Georgia, Augusta, Georgia 30912

In this study we continue our examination of the unique form of antibody-dependent antitumor cytotoxicity (ADCC) which develops when human monocytes are exposed to macrophage colony-stimulating factor (MCSF) in vitro. This form of ADCC is not present in fresh monocytes and emerges only as monocytes differentiate into monocyte-derived macrophages (MDM). We now report that the presence of -interferon (IFN-) during this period of differentiation markedly affects the development of MCSF-induced cytotoxicity. The addition of IFN- on day 0 resulted in a pronounced dose-dependent inhibition of ADCC measured on day 7 (mean inhibition, 76 ± 12%; range, 66–94%). MDM exposed to MCSF plus IFN- required 3–10-fold higher effector to target cell ratios to achieve a level of cytotoxicity comparable to that of MDM cultured with MCSF alone. This inhibitory effect was attributable to an IFN--induced shift in the basic mechanism of target cell killing, away from the phagocytic form normally seen with MCSF and toward a significantly less effective extra-cellular form. In order to influence ADCC, IFN- had to be present prior to the onset of differentiation; if it was added later it had progressively less effect, and if it was added after differentiation was complete it was inactive. The modulatory effects of IFN- also extended to a number of other developmentally regulated attributes. MDM cultured with MCSF normally acquired a characteristic morphology and immunophenotype, reentered the cell cycle, and changed functionally from accessory cells for mitogen-induced lymphocyte activation to suppressor cells. The presence of IFN- prevented the emergence of each of these attributes. Despite these negative effects, MDM exposed to IFN- remained viable, continued to bind and internalize MCSF, and displayed superior accessory cell function and oxidative burst activity. Taken together, our findings suggest that human monocytes are capable of following at least two distinct differentiation pathways in response to the local cytokine environment, with significant impact on the resultant macrophage phenotype in general and antitumor cytotoxicity in particular.

¹ Supported in part by grants from the American Cancer Society (IRG 174b), the Fraternal Order of Eagles, and the Medical College of Georgia Research Institute. Portions of this material were presented in abstract form at the 33rd Annual Meeting of the American Society of Hematology, December 1991.

² To whom requests for reprints should be addressed, at the Division of Pediatric Hematology-Oncology, Medical College of Georgia, Room CK-146, 1120 15th Street, Augusta, GA 30912-3730.

Received 12/ 7/92. Accepted 3/24/93.

This article has been cited by other articles:

				R. L. Seymour, V. Ganapathy, A. L. Mellor, and D. H. Munn A high-affinity, tryptophan-selective amino acid transport system in human macrophages J. Leukoc. Biol., December 1, 2006; 80(6): 1320 - 1327. [Abstract] [Full Text] [PDF]

				I. O. Gordon and R. S. Freedman Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients Clin. Cancer Res., March 1, 2006; 12(5): 1515 - 1524. [Abstract] [Full Text] [PDF]

				P. Terness, J.-J. Chuang, T. Bauer, L. Jiga, and G. Opelz Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? Blood, March 15, 2005; 105(6): 2480 - 2486. [Abstract] [Full Text] [PDF]

				T. Keler, P. K. Wallace, L. A. Vitale, C. Russoniello, K. Sundarapandiyan, R. F. Graziano, and Y. M. Deo Differential Effect of Cytokine Treatment on Fc{alpha} Receptor I- and Fc{gamma} Receptor I-Mediated Tumor Cytotoxicity by Monocyte-Derived Macrophages J. Immunol., June 1, 2000; 164(11): 5746 - 5752. [Abstract] [Full Text] [PDF]

				D. H. Munn, E. Shafizadeh, J. T. Attwood, I. Bondarev, A. Pashine, and A. L. Mellor Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism J. Exp. Med., May 3, 1999; 189(9): 1363 - 1372. [Abstract] [Full Text] [PDF]

				D. H. Munn, M. Zhou, J. T. Attwood, I. Bondarev, S. J. Conway, B. Marshall, C. Brown, and A. L. Mellor Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism Science, August 21, 1998; 281(5380): 1191 - 1193. [Abstract] [Full Text]

				N. Marczin, A. Antonov, A. Papapetropoulos, D. H. Munn, R. Virmani, F. D. Kolodgie, R. Gerrity, and J. D. Catravas Monocyte-Induced Downregulation of Nitric Oxide Synthase in Cultured Aortic Endothelial Cells Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1095 - 1103. [Abstract] [Full Text]

				A. Papapetropoulos, A. Antonov, R. Virmani, F. D. Kolodgie, D. H. Munn, N. Marczin, J. W. Ryan, R. G. Gerrity, and J. D. Catravas Monocyte- and Cytokine-Induced Downregulation of Angiotensin-Converting Enzyme in Cultured Human and Porcine Endothelial Cells Circ. Res., September 1, 1996; 79(3): 512 - 523. [Abstract] [Full Text]

				H.-B. Peng, T. B. Rajavashisth, P. Libby, and J. K. Liao Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells J. Biol. Chem., July 14, 1995; 270(28): 17050 - 17055. [Abstract] [Full Text] [PDF]